Advertisement
Advertisement

DCTH

DCTH logo

Delcath Systems Inc

15.11
USD
Sponsored
-0.36
-2.33%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

14.91

-0.20
-1.32%

DCTH Earnings Reports

Positive Surprise Ratio

DCTH beat 16 of 29 last estimates.

55%

Next Report

Date of Next Report
Nov 02, 2026
Estimate for Q3 26 (Revenue/ EPS)
$25.68M
/
-$0.22
Implied change from Q2 26 (Revenue/ EPS)
-11.85%
/
-414.29%
Implied change from Q3 25 (Revenue/ EPS)
+24.88%
/
-1200.00%

Delcath Systems Inc earnings per share and revenue

On Aug 06, 2026, DCTH reported earnings of 0.07 USD per share (EPS) for Q2 26, beating the estimate of -0.09 USD, resulting in a 176.25% surprise. Revenue reached 29.13 million, compared to an expected 26.78 million, with a 8.76% difference. The market reacted with a +22.49% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 6 analysts forecast an EPS of -0.22 USD, with revenue projected to reach 25.68 million USD, implying an decrease of -414.29% EPS, and decrease of -11.85% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Tandem Diabetes Care, Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.32
Actual
-$0.31
Surprise
+4.94%
logo
Artivion, Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.01
Actual
$0.13
Surprise
+1,174.51%
logo
Treace Medical Concepts, Inc. Common Stock
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$0.30
Actual
-$0.24
Surprise
+21.05%
logo
Inogen Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.15
Actual
-$0.14
Surprise
+10.88%
logo
CVRx, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.53
Actual
-$0.53
Surprise
+0.90%
logo
Rapid Micro Biosystems, Inc. Class A Common Stock
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$0.24
Actual
-$0.27
Surprise
-8.78%
logo
Hyperfine, Inc. Class A Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.09
Actual
-$0.09
Surprise
+1.96%
logo
GLOBUS MEDICAL INC
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.12
Actual
$1.34
Surprise
+19.50%
logo
Teleflex Incorporated
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.29
Actual
$1.76
Surprise
+36.04%
logo
Pulse Biosciences, Inc Common Stock (DE)
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.36
Actual
-$0.36
Surprise
+1.96%
FAQ
For Q2 2026, Delcath Systems Inc reported EPS of $0.07, beating estimates by 176.25%, and revenue of $29.13M, 8.76% above expectations.
The stock price moved up 22.49%, changed from $12.63 before the earnings release to $15.47 the day after.
The next earning report is scheduled for Nov 02, 2026.
Based on 6 analysts, Delcath Systems Inc is expected to report EPS of -$0.22 and revenue of $25.68M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement